: A Novel ROS1 Oncogenic Fusion Detected on Next Generation Sequencing
Advanced Non-Small Cell Lung Carcinoma (NSCLC) patients with ROS1 gene rearrangement have shown significant therapeutic responses to tyrosine kinase inhibitors approved by the US Food and Drug Administration, with approximately 40 fusion partners documented in the existing literature. Our report hig...
Saved in:
Main Authors: | Anurag Mehta (Author), Himanshi Diwan (Author), Shrinidhi Nathany (Author), Ullas Batra (Author), Manoj Gupta (Author), Manoj Kumar Panigrahi (Author), Dushyant Kumar (Author), Sakshi Mattoo (Author), Aayushi Singh (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Robust home brew fragment sizing assay for detection of MET exon 14 skipping mutation in non-small cell lung cancer patients in resource constrained community hospitals
by: Anurag Mehta, et al.
Published: (2021) -
Extradural spinal melanoma: is it primary or metastatic? A case report with a brief review of literature
by: Raghav Kapoor, et al.
Published: (2024) -
Founder mutations in Nepalese population
by: Anurag Mehta, et al.
Published: (2022) -
Discordant EGFR mutation results: A case report
by: Ullas Batra, et al.
Published: (2022) -
TTF1-positive SMARCA4/BRG1 deficient lung adenocarcinoma
by: Anurag Mehta, et al.
Published: (2022)